Morgan Jess S & CO Inc Oramed Pharmaceuticals Inc. Transaction History

Morgan Jess S & CO Inc

$115 Million
Q3 2022

A detailed history of Morgan Jess S & CO Inc transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Morgan Jess S & CO Inc holds 366,401 shares of ORMP stock, worth $853,714. This represents 2.07% of its overall portfolio holdings.

Number of Shares

366,401

Previous 315,301 16.21%

Holding current value

$853,714

Previous $1.44 Million 64.4%

% of portfolio

2.07%

Previous 1.5%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$4.6 - $9.91 $235,059 - $506,401	51,100 Added 16.21%	366,401 $2.37 Million
Q2 2022 Jul 18, 2022	BUY	$3.72 - $9.0 $92,256 - $223,200	24,800 Added 8.54%	315,301 $1.44 Million
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $615,069 - $1.04 Million	75,100 Added 34.87%	290,501 $2.51 Million
Q4 2021 Jan 27, 2022	BUY	$12.98 - $29.75 $2.8 Million - $6.41 Million	215,401 New	215,401 $3.08 Million
Q3 2021 Nov 09, 2021	SELL	$12.13 - $23.82 $3.91 Million - $7.68 Million	-322,249 Closed	0 $0
Q2 2021 Nov 30, 2021	SELL	$8.34 - $14.59 $481,176 - $841,770	-57,695 Reduced 15.19%	322,249 $4.31 Million
Q1 2021 Nov 30, 2021	SELL	$4.22 - $11.33 $832,914 - $2.24 Million	-197,373 Reduced 34.19%	379,944 $3.86 Million
Q4 2020 Nov 30, 2021	BUY	$2.48 - $4.64 $2,480 - $4,640	1,000 Added 0.17%	577,317 $2.45 Million
Q3 2020 Nov 29, 2021	BUY	$2.58 - $4.16 $421,633 - $679,843	163,424 Added 39.58%	576,317 $1.5 Million
Q2 2020 Nov 29, 2021	BUY	$2.87 - $4.12 $1.09 Million - $1.57 Million	380,993 Added 1194.34%	412,893 $1.46 Million
Q1 2020 Nov 29, 2021	BUY	$2.6 - $5.5 $2,600 - $5,500	1,000 Added 3.24%	31,900 $97,000
Q4 2019 Nov 19, 2021	BUY	$2.43 - $5.74 $75,087 - $177,366	30,900 New	30,900 $159,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.4M

Call Options Held

Put Options Held

2.1K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.5M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Jess S & CO Inc with notifications on news.

Account

Morgan Jess S & CO Inc Oramed Pharmaceuticals Inc. Transaction History